Catherine Coste
Board Member
Renalytix plc (RNLXY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Catherine Coste
Catherine Coste is recorded as Board Member at Renalytix plc (RNLXY). Earlier roles on record: Board Member at Biomerica Inc (BMRA) until June 4, 2025. Renalytix plc reported in an 8-K filed July 3, 2023 that Catherine Coste was appointed Non-Executive Chair of the Audit Committee, effective June 30, 2023. Renalytix plc reported in an 8-K filed July 3, 2023 that Catherine Coste was appointed Director, effective June 30, 2023.
“Ms. Coste was also appointed as the Non-Executive Chair of the Audit Committee and a member of the Renumeration Committee, effective June 30, 2023.”
“On June 30, 2023, Catherine Coste was appointed to the Board of Directors (the "Board") of Renalytix plc (the "Company").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Renalytix plc (RNLXY)
SEC 8-K
Current2023-06-30–present
-
Current
Start not stated–present
-
2020-01-01–2025-06-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Renalytix plc
Other people whose current roles at this company are on record from its filings.
- James McCullough CEO, Board Member
- Julian Baines MBE Chairman, Board Member
- Joel Jung CFO
- Joel R. Jung CFO
- Christopher Mills Board Member
- Erik Lium Board Member
- Fergus Fleming Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.